Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eneti Says President Of Co Purchased 25K Shares At Average Price Of $8.64/Share

Eneti Inc. (NYSE:NETI) (the "Company") announced today that the President of the Company, Robert Bugbee, has recently purchased 25,000 common shares of the Company at an average price of $8.64 per

byBenzinga Newsdesk

November 17, 2021

1 minute read

Eneti Inc. (NYSE:NETI) (the “Company”) announced today that the President of the Company, Robert Bugbee, has recently purchased 25,000 common shares of the Company at an average price of $8.64 per share in the open market.

Canaccord Genuity Upgrades Xebec Adsorption to Buy, Raises Price Target to $6

By Benzinga Newsdesk

Today, 7:26 AM

Canaccord Genuity analyst Yuri Lynk upgrades Xebec Adsorption (OTC:XEBEF) from Hold to Buy and raises the price target from $4.5 to $6.

XEBEF

Why Jim Cramer Prefers Nvidia To 3D Systems

By Craig Jones

Today, 7:26 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he doesn’t like the balance sheet of AT&T Inc (NYSE: T) and is also very concerned about the spin-off of WarnerMedia.

DDD

EU Mandates Standard Charger For Apple iPhones And Other Devices

By Anusuya Lahiri

Today, 7:26 AM

A provisional EU agreement mandated smartphones and tablets to use a standard charger.

AAPL

Aldeyra Therapeutics’ RASP Modulator Shows Improved Signs of Alcohol Intoxication

By Vandana Singh

Today, 7:26 AM

Aldeyra Therapeutics Inc (NASDAQ:ALDX) announced a demonstration of target engagement and improvement in the signs of alcohol intoxication in the Phase…

ALDX

Eneti Says President Of Co Purchased 25K Shares At Average Price Of $8.64/Share

Related Posts

Canaccord Genuity Upgrades Xebec Adsorption to Buy, Raises Price Target to $6

Why Jim Cramer Prefers Nvidia To 3D Systems

EU Mandates Standard Charger For Apple iPhones And Other Devices

Aldeyra Therapeutics’ RASP Modulator Shows Improved Signs of Alcohol Intoxication